Literature DB >> 12168155

[Diagnosis related groups in stroke treatment. An analysis from the stroke data bank of the German Stroke Foundation].

C Weimar1, J Stausberg, K Kraywinkel, M Wagner, O Busse, R L Haberl, H-C Diener.   

Abstract

BACKGROUND: The upcoming introduction of diagnosis related groups (DRG) as an exclusive base for future calculation of hospital proceeds in Germany requires a thorough analysis of cost data for various diseases.
OBJECTIVE: To compare the resulting combined cost weights of the Australian Refined DRG system (AR-DRG) with the proceeds based on actual per-day rates in stroke treatment. PATIENTS AND METHODS: Between 1998 and 1999, data from 6520 patients (median age 68 years, 43% women) with acute stroke or transient ischemic attack (TIA) were prospectively documented in 15 departments of Neurology with an acute stroke unit, 9 departments of general Neurology and 6 departments of Internal Medicine. Prior to grouping cases into DRGs, all available data were transferred into ICD-10-SGB-V 2.0 or the Australian procedure system (MBS-Extended). Hospital proceeds for the respective cases were calculated based on per-day rates of the documenting hospitals.
RESULTS: The resulting cost weights demonstrate a good homogeneity compared to the length of stay. When introducing the AR-DRG with a uniform base rate in Germany, a relative decrease of hospital proceeds can be expected in Neurology Departments and for treatment of TIAs.
CONCLUSION: Preservation of the existing structure of acute stroke care in Germany requires a supplement to a uniform base rate in Neurology departments.

Entities:  

Mesh:

Year:  2002        PMID: 12168155     DOI: 10.1055/s-2002-33200

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

1.  [Costs of stroke unit care in Germany. Resource use and reimbursements by German diagnosis related groups].

Authors:  T Back; M Schaeg; C Back; Y Epifanov; T Hemmen; R C Dodel; O Schöffski
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.